WASHINGTON, Dec. 16 -- Internal Revenue Service has issued a rule called: Entities Wholly Owned by Indian Tribal Governments. The rule was published in the Federal Register on Dec. 16 by Frank J. Bis... Read More
WASHINGTON, Dec. 16 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, a... Read More
WASHINGTON, Dec. 16 -- Commodity Futures Trading Commission has issued a rule called: Withdrawal of Interpretive Guidance: Retail Commodity Transactions Involving Certain Digital Assets. The rule was... Read More
WASHINGTON, Dec. 16 -- Federal Aviation Administration has issued a rule called: Modification and Revocation of Class E Airspace; Hawaiian Islands, HI; Correction. The rule was published in the Feder... Read More
WASHINGTON, Dec. 16 -- Federal Aviation Administration has issued a rule called: Airworthiness Directives; Airbus Helicopters Deutschland GmbH (AHD) Helicopters. The rule was published in the Federal... Read More
WASHINGTON, Dec. 16 -- Sen. Elizabeth Warren issued the following press release: U.S. Senator Elizabeth Warren (D-Mass.), Ranking Member of the Senate Banking, Housing, and Urban Affairs Committee, a... Read More
WASHINGTON, Dec. 16 -- Sen. Elizabeth Warren issued the following press release: In a new letter, U.S. Senator Elizabeth Warren (D-Mass.) and Representative John Garamendi (D-Calif.), both members of... Read More
WASHINGTON, Dec. 16 -- Office of the Comptroller of the Currency has issued a rule called: Appraisals for Higher-Priced Mortgage Loans Exemption Threshold. The rule was published in the Federal Regis... Read More
U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282145) titled 'Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers' on Nov. 17. Brief Summa... Read More
U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281664) titled 'Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line T... Read More